Whan In Pharm Co.,Ltd. (KRX:016580)
South Korea · Delayed Price · Currency is KRW
10,310
-80 (-0.77%)
At close: Feb 6, 2026
Whan In Pharm Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|
| Feb '26 Feb 5, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
|---|
| 157,403 | 180,304 | 229,617 | 268,700 | 271,754 | 254,960 |
| -15.07% | -21.48% | -14.54% | -1.12% | 6.59% | 8.09% |
| 98,475 | 129,280 | 155,357 | 180,073 | 139,039 | 131,637 |
| 10310.00 | 11504.57 | 14288.98 | 16384.71 | 16287.63 | 15021.36 |
| 10.54 | 7.71 | 7.71 | 11.23 | 10.19 | 10.90 |
| 0.61 | 0.70 | 1.00 | 1.35 | 1.53 | 1.49 |
| 0.40 | 0.48 | 0.64 | 0.81 | 0.86 | 0.86 |
| 0.41 | 0.49 | 0.65 | 0.81 | 0.87 | 0.87 |
| 27.72 | - | - | - | 8.79 | 17.27 |
| 15.28 | 8.71 | 9.90 | 15.95 | 7.69 | 11.21 |
| 0.38 | 0.50 | 0.67 | 0.91 | 0.78 | 0.77 |
| 4.26 | 4.31 | 4.22 | 5.20 | 3.92 | 4.05 |
| 7.39 | 6.01 | 5.15 | 6.04 | 4.45 | 4.63 |
| 17.35 | - | - | - | 4.50 | 8.91 |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| 0.03 | 0.01 | 0.02 | 0.01 | 0.05 | 0.07 |
| 0.13 | - | - | - | 0.06 | 0.15 |
| 0.59 | 0.63 | 0.60 | 0.55 | 0.52 | 0.54 |
| 2.20 | 2.62 | 2.89 | 2.87 | 2.58 | 2.79 |
| 3.24 | 3.03 | 3.93 | 5.03 | 6.77 | 6.77 |
| 5.56 | 4.75 | 5.30 | 6.22 | 7.85 | 8.02 |
| 3.95% | 6.37% | 8.60% | 7.29% | 8.62% | 8.12% |
| 1.80% | 3.25% | 4.89% | 5.16% | 5.73% | 5.60% |
Return on Invested Capital (ROIC) | 3.56% | 6.17% | 10.08% | 11.31% | 13.77% | 12.25% |
Return on Capital Employed (ROCE) | 3.10% | 5.60% | 8.40% | 8.80% | 9.70% | 9.40% |
| 9.64% | 12.97% | 12.97% | 8.90% | 9.81% | 9.17% |
| 3.61% | -3.70% | -3.19% | -6.25% | 11.38% | 5.79% |
| 2.91% | 2.61% | 2.10% | 1.83% | 1.84% | 2.00% |
| 30.20% | 19.59% | 15.38% | 19.15% | 17.18% | 19.58% |
| -1.53% | - | - | - | - | - |
| 1.36% | 2.61% | 2.10% | 1.83% | 1.84% | 2.00% |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.